EGFR and carcinoma: Moreover, EGFR ligands act on cell proliferation at picomolar concentrations while they display inhibitory effects at higher doses in numerous cells such as carcinoma [44], [45], fibroblastic cell lines [46] and primary keratinocytes [47].